Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Inhibitory effects of bark extracts from Ulmus laevis on endometrial carcinoma
European Journal of Cancer Prevention, 04/08/09
Paschke D et al. - Concentrations of 500 ug/ml induced a significant inhibition of cell vitality up to 80% and cell proliferation up to 81.5%. A significant cytotoxity was not observed. The results lead to the assumption that the bark extract from Ulmus laevis has antiproliferation and anticancer potential in hormone-dependent endometrial carcinoma cells.
Related Articles
Local Biosynthesis of Estrogen in Human Endometrial Carcinoma through Tumor-Stromal Cell Interactions
Clinical Cancer Research, 10/06/09
Relevance Score: 70%
Endometrial Cancer
American Family Physician, 11/12/09
Relevance Score: 68%
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
Modern Pathology, 10/28/09
Relevance Score: 68%
Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction
Acta Obstetricia et Gynecologica Scandinavica, 10/09/09
Relevance Score: 67%
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
American Journal of Obstetrics and Gynecology, 10/08/09
Relevance Score: 67%
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
Carcinogenesis, 12/01/09
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
Cancer Treatment Reviews, 11/19/09
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Human papillomavirus infection in women with and without cervical cancer in Nepal
Cancer Causes and Control, 12/01/09
Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation
Diagnostic Cytopathology, 12/01/09
Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin ; An evaluation of the therapeutic index with special emphasis on cardiac toxicity
Chemotherapy, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


